Peloton Therapeutics

pelotontherapeutics.com

Peloton therapeutics, inc., is a clinical-stage biotechnology company that discovers and develops novel small molecule cancer therapies targeting unexploited molecular vulnerabilities. Peloton therapeutics’ lead programs are small molecule inhibitors targeting hypoxia inducible factor-2α (hif-2α), a transcription factor implicated in the development and progression of kidney and other cancers.